Quest Diagnostics has partnered with Paige to develop software products leveraging artificial intelligence (AI) to enhance and expedite the pathologic diagnoses of cancer and various other diseases.
Using Paige’s machine learning capabilities, the partnership will analyse pathology diagnostic data and digitised slides from Quest as well as its AmeriPath and Dermpath units to identify markers of cancer and other indications.
Using this data, the companies plan to create new software products that can be used for disease diagnoses by pathologists and oncologists, among others.
